Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Gestodene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR known ✓ | P06401 | 7/20 | 1.00 |
| ▸ | AR | P10275 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 4/20 | 1.00 |
| ▸ | ESR1 | P03372 | 4/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.66 |
| ▸ | ABCB11 | O95342 | 4/20 | 0.66 |
| ▸ | SHBG | P04278 | 4/20 | 0.66 |
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.53 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gestodene SCHEMBL5031715 | 1.00 | PGR (1.00) | PGRARLMNASLC6A4ESR1 | |
| Gestodene SCHEMBL14983004 | 1.00 | PGR (1.00) | PGRARLMNASLC6A4ESR1 | |
| Gestodene SCHEMBL15263394 | 1.00 | PGR (1.00) | PGRARLMNASLC6A4ESR1 | |
| Gestodene SCHEMBL16661464 | 1.00 | PGR (1.00) | PGRARLMNASLC6A4ESR1 | |
| Gestodene SCHEMBL1650027 | 1.00 | PGR (1.00) | PGRARLMNASLC6A4ESR1 | |
| Gestodene SCHEMBL2335657 | 1.00 | PGR (1.00) | PGRARLMNASLC6A4ESR1 | |
| Gestodene SCHEMBL354831 | 0.96 | PGR (0.93) | PGRARLMNASLC6A4ESR1 | |
| Gestodene SCHEMBL4467096 | 0.95 | PGR (0.91) | PGRARLMNASLC6A4ESR1 | |
| Gestodene SCHEMBL1467970 | 0.92 | PGR (0.84) | PGRARLMNASLC6A4ESR1 | |
| Gestodene SCHEMBL4473794 | 0.91 | PGR (0.83) | PGRARLMNASLC6A4ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6901 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4440706-B1 | COMPOSITIONS FOR PROMOTING HAIR GROWTH | ESTETRA SRL (BE) | 2026-04-29 | — | — | EP | claimed |
| US-20260090995-A1 | ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT | ESTETRA SRL (BE) | 2026-04-02 | — | — | US | claimed |
| US-20260053736-A1 | LONG ACTING DRUG DELIVERY DEVICE AND ITS USE IN CONTRACEPTION | BAYER OY (FI) | 2026-02-26 | — | — | US | claimed |
| EP-4463570-B1 | METHOD FOR HORMONE OR DRUG SCREENING IN A TISSUE SAMPLE | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2026-01-14 | — | — | EP | claimed |
| US-20260000613-A1 | INJECTABLE CONTROLLED-RELEASE FORMULATIONS OF PROGESTOGEN DRUGS | FORDOZ PHARMA CORP. (US) | 2026-01-01 | — | — | US | claimed |
| EP-4653499-A2 | SILICONE MATERIAL, SILICONE TUBE, IMPLANT, PHARMACEUTICAL COMPOSITION, AND TEST METHOD FOR AMOUNT OF DRUG RELEASED | SHENYANG XINGHUA PHARMACEUTICAL TECHNOLOGY CO., LTD (CN) | 2025-11-26 | — | — | EP | claimed |
| EP-4643858-A1 | METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF UTERINE DISEASE | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-11-05 | — | — | EP | claimed |
| EP-4637777-A1 | USE OF ESTETROL IN HEPATICALLY IMPAIRED PATIENTS | Estetra SRL (BE) | 2025-10-29 | — | — | EP | claimed |
| US-12427114-B2 | Orodispersible dosage unit containing an estetrol component | ESTETRA SRL (BE) | 2025-09-30 | — | — | US | claimed |
| EP-3787631-B1 | MODULATORS OF ORPHAN NUCLEAR RECEPTORS FOR NASH AND OTHER METABOLIC DISORDERS | UNIV EMORY (US) | 2025-09-10 | — | — | EP | claimed |
| EP-0309263-A2 | Hormone composition and use | JENCAP RESEARCH LIMITED (CA) | 1989-03-29 | — | — | EP | claimed |
| CN-1031323-A | CONTRACEPTIVE IMPLANT | AKZO NV (NL) | 1989-03-01 | — | — | CN | claimed |
| EP-0303306-A1 | Contraceptive implant | AKZO N.V. (NL) | 1989-02-15 | — | — | EP | claimed |
| US-4794119-A | Aqueous crystalline suspension of steroid glycoesters | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-12-27 | — | — | US | claimed |
| EP-0148724-B1 | SEQUENTIAL COMBINED MULTIPHASE PREPARATION AND ITS USE FOR ORAL CONTRACEPTION | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-06-01 | — | — | EP | claimed |
| WO-1988000469-A1 | COMBINATION DOSAGE FORM FOR PRE-MENOPAUSAL WOMEN | AMERICAN HOME PRODUCTS CORPORATION (US) | 1988-01-28 | — | — | WO | claimed |
| EP-0253607-A1 | Combination dosage form for premenopausal women | AMERICAN HOME PRODUCTS CORPORATION (US) | 1988-01-20 | — | — | EP | claimed |
| EP-0050867-B1 | VAGINAL RING | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-01-13 | — | — | EP | claimed |
| US-4621079-A | GESTODENE AND ETHINYLESTRADIOL | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-11-04 | — | — | US | claimed |
| US-4081537-A | PROGESTATIONAL, OVULATION INHIBITORS, NIDATION INHIBITORS | SCHERING AKTIENGESELLSCHAFT (DT) | 1978-03-28 | — | — | US | claimed |